Intuitive Surgical, Inc. reported second quarter 2026 financial results, with revenue of $2.89 billion, a 19% increase compared to the second quarter of 2025. GAAP net income attributable to the company was $818 million, or $2.29 per diluted share, while non-GAAP net income was $1.00 billion, or $s2.80 per share. Worldwide procedure volume grew approximately 16%, driven by da Vinci and Ion systems. The company repurchased 0.9 million shares of its common stock for $0.38 billion in the quarter. Intuitive Surgical, Inc. is a global technology leader in minimally invasive care and robotic-assisted surgery.
